Allspring Global Investments Holdings, LLC Agios Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 379 shares of AGIO stock, worth $15,664. This represents 0.0% of its overall portfolio holdings.
Number of Shares
379
Previous 651
41.78%
Holding current value
$15,664
Previous $19,000
15.79%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AGIO
# of Institutions
227Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$234 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$227 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$201 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$160 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$115 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.27B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...